Chemoprophylaxis refers to the use of chemical agents, such as drugs or medications, to prevent the development or spread of infectious diseases. This proactive approach is often employed in situations where the risk of infection is high, such as during outbreaks or in specific populations with increased vulnerability. Common examples of chemoprophylaxis include the use of antibiotics to prevent bacterial infections, antimalarial drugs for travelers visiting regions with malaria, and antiviral medications for preventing certain viral infections. The choice of the chemoprophylactic agent depends on the specific pathogen and the characteristics of the population at risk. Chemoprophylaxis is widely utilized in public health strategies, such as in the prevention of sexually transmitted infections, tuberculosis, and certain parasitic diseases. The effectiveness of chemoprophylaxis relies on factors like the timing of administration, compliance with the prescribed regimen, and the emergence of drug resistance. While chemoprophylaxis is a valuable tool in disease prevention, its use requires careful consideration of factors such as potential side effects, the development of resistance, and the overall impact on public health. Proper education, monitoring, and adherence to guidelines are crucial for the success of chemoprophylaxis programs.
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya